Today, we recap the World Vaccine Congress in Washington, D.C., and look at a recent report highlighting the economic and environmental benefits of biobased products. Enjoy the weekend. (532 words, 2 minutes, 39 seconds)
The Committee concentrates on tax, financial services, securities, and accounting policies that impact member companies and biotech capital formation. This committee advises BIO staff about the impact of legislation and regulations affecting these policy matters and supports BIO’s engagement with Treasury, the SEC, and the IRS, as well as Congress and the Administration.
For more information and to join the Committee, please contact Emily Berst (eberst@bio.org).
Breaking this morning: BIO President and CEO John F. Crowley writes in STAT News why the U.S. must maintain its leadership in biotechnology (and how). Plus, dengue is spreading—and warmer weather is to blame. (581 words, 2 minutes, 54 seconds)
The BIO International Convention attracts 15,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships. Position yourself for success at this year's event, June 3-6, in San Diego! BIO is where business and breakthroughs converge – and the BIO One-on-One Partnering™ system facilitates the connections that fuel our industry.
Attend this webinar to learn more about what’s happening at BIO 2024 and what the BIO One-on-One Partnering™ system can do for your business goals. Explore the program, networking opportunities, partnering system fundamentals, gain insight to best practices for partnering, and much more! For more information and to register for BIO 2024, please visit: convention.bio.org
Speakers:
Bernard Fallon, Managing Director, Industry Research and Education, BIO
Mackensie Vernetti, Vice President, Partnering, BIO
